Publications
148
Citations
7,101
Est. group size
~26
Recurring co-author estimate
Active years
60
Publishing since 1967
Typically publishes in teams of ~6 · 16% small-team papers (≤3 authors) · across 36 venues
- Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity
Molecular Oncology · 2026
- 2025 Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization
mAbs · 2026
- Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties
mAbs · 2026
- Ultra-Dilute Developability Analysis of Antibody Self-Association and Non-Specific Binding
Methods in molecular biology · 2026
- Multi-objective antibody design and optimization using machine learning
Nature Reviews Bioengineering · 2026
- Decoding Bispecific Antibody Developability: Design Rules and Predictive Models from a 160-Member Library
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
mAbs · 2025
- Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixtures
mAbs · 2025
- A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- 224 Antibody/peptide-nanoparticle conjugates for specific cell-type targeting of genetic therapies
Journal of Cystic Fibrosis · 2025
- Impacts of Antibody Structure and Mixtures on Receptor Signaling for Antibody-Dependent Cellular Cytotoxicity
The AAPS Journal · 2025
- AIntibody: an experimentally validated in silico antibody discovery design challenge
Nature Biotechnology · 2024
- Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases
BioDrugs · 2024
- Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions
Cell Reports · 2024
- Development of a pan‐tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregates
Biotechnology Progress · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×11
- mAbs×10
- Molecular Pharmaceutics×6
- Cell chemical biology×4
- Nature Communications×3
- Emily K. Makowski
Medicine · University of Michigan
- Samuel D. Stimple
Medicine · The Ohio State University
- Jennifer M. Zupancic
Medicine · University of Michigan
- Alec A. Desai
Medicine · University of Michigan
- L.D. Ward
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile